chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This nurse was alerted to call pt today due to pt had left message at department with concerns of a reaction. On talking to pt she states that she started to have hardness, itching, redness, and warmth to left arm under injection site on Feb 14th. Pt states that this area is now 5inches long and 2 1/2 inches wide. This nurse instructed pt to outline redness with a black marker to see if redness continues to increase. If redness does keep increasing pt go to a MD right away as she might need antibiotics. This nurse reviewed that pt should try neosporin and ice to site for now. Pt agrees with this plan. This nurse also gave pt her phone number for any further questions.
An abcess devel @ inject site in a brother & sister who recvd DT vax @ different times & different places & from different packages;
Felt light headed or dizzy almost felt like I was drunk; Felt light headed or dizzy almost felt like I was drunk; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 59 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 05Apr2021 16:00 (Batch/Lot number: unknown) at the age of 59 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose number: 1, Product: COVID 19, Brand: Pfizer, Administration time: 04:00 PM, Vaccine location: Left arm,), administration date: 15Mar2021, when the patient was 59 years old, for COVID-19 immunization. The following information was reported: DIZZINESS (non-serious), FEELING DRUNK (non-serious) all with onset 09Apr2021 10:00, outcome "recovered" (Apr2021) and all described as "Felt light headed or dizzy almost felt like I was drunk". The event "felt light headed or dizzy almost felt like i was drunk" and "felt light headed or dizzy almost felt like i was drunk" was evaluated at the emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of dizziness, feeling drunk. Additional information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No known allergies. The patient was not diagnosed with COVID prior vaccination. Had to be taken by ambulance to emergency room. Blood work was done iv was given meclizine 25mg x2. All tests came back negative of anything being wrong.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
The shot was only given 3 months after the last booster dose on 1/04/2022,  earlier than the 4 month recommendation
Fever, headache, muscle pain, abdominal pain and what really worries me is that all these symptoms have disappeared. But I have a kind of blister on my genitals and that has not disappeared. All the symptoms appeared the same day I received the second dose of the vaccine (in the first dose I received I did not have any problems or strange symptoms), except for the blister that appeared two days later.
Rash not at injection site; Facial swelling; Lip swelling; Fatigue; joint pain; Muscle aches; Headache; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Epb955) via an unspecified route of administration in the left arm on 07Apr2021 at 14:30 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history included polymorphic light eruption, deaf in left ear since birth, vitreous gel detachment, epiretinal membrane, polycystic ovarian syndrome, COVID-19 on unknown dates, latex allergy, caffeine allergy (coffee), allergy to plants (chamomile and cilantro), vegetable allergy (cucumbers and rutabaga), spice allergy (cumin) and allergy to wasp stings (wasps). The patient received unspecified medications within two weeks of vaccination for unknown indications on unknown dates. The patient previously received codeine (MANUFACTURER UNKNOWN) for an unknown indication on an unknown date and experienced allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 07Apr2021 at 15:30, the patient experienced rash not at injection site, facial and lip swelling, fatigue, joint pain, muscle ache and headache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events rash not at injection site, facial and lip swelling, fatigue, joint pain, muscle ache and headache were recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
covid vaccine breakthrough case  dose 1 Moderna 6/11/21  050C21A
Fever; Chills; Weakness; Tiredness; Nausea; Pain; Extreme headache; Confusion; This is a spontaneous report received from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in her right arm on 23Feb2021 at 09:45 (at the age of 39-years-old), received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP7534), via an unspecified route of administration in her right arm on 16Mar2021 at 09:45 (at the age of 39-years-old) for COVID-19 immunisation. The patient's medical history included allergic to Penicillin. The patient did not receive any concomitant medications within two weeks prior to the second dose of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 16Mar2021 at 09:45, the patient experienced fever, chills, weakness, tiredness, nausea, pain, extreme headache and confusion. The patient did not receive any treatment for the events. The clinical outcome of the events of fever, chills, weakness, tiredness, nausea, pain, headache and confusion were not recovered.   No follow-up attempts are needed. No further information is expected.
Itching on whole body. Pt is known to have had anaphylaxis before w/other meds, allergies reportedly pt. PNCs, sulfas, ibu, iodine red welts on neck & arms, legs.
At Midnight 24 hours later I felt a burning sensation in both legs. I did not have a fever. The burning sensation lasted 1 hour.
swollen lymph nodes; she has a tumor on her kidney.; she had the first dose of the Pfizer covid 19 vaccine on 6Jan2021 and the second dose on 23Jan2021.; This is a spontaneous report from a contactable consumer (patient). A 44-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration administered in right arm in a hospital facility on 23Jan2021 11:00 (at the age of 44-year-old) (Batch/Lot Number: Z9262) as 2ND DOSE, SINGLE DOSE for covid-19 immunisation. The patient had no prior vaccinations within 4 weeks. Medical history included anxiety. The patient's family history includes her dad with diabetes and her mom had high blood pressure. Concomitant medication included hydroxyzine pamoate taken for anxiety from Sep2020 to an unspecified stop date. Historical vaccine includes the first dose of bnt162b2 (lot number: EJ1686) administered in the right arm on 06Jan2021 at 10:00 AM (at the age of 44-year-old) for COVID-19 immunization. The patient stated that she had the first dose of the Pfizer covid 19 vaccine on 06Jan2021 and the second dose on 23Jan2021. The patient had a computerized tomogram (CT) scan on 03Apr2021 and saw a specialist on 14May2021. The specialist informed her that she has a tumor on her kidney on 14May2021. Patient stated that she will see a surgeon on 08Jun2021. The patient stated that she wanted to avoid extra expenses and avoid surgery if this was related to the vaccine like swollen lymph nodes and mammograms. Patient wanted to know if this has been reported. The patient added that on 08Jun2021 she will be going to a kidney specialist; on 01Jun2021, she was scheduled for a magnetic resonance imaging (MRI) follow up. Patient also added previously that she was going to have a surgery for her stomach called lower anterior resection but now she does not know what will happen. Stated she has a follow up on 28May2021 to find out what he will do. Mentioned that the she went to see the stomach doctor for issues she was having with her stomach and he ordered the CT scan and then referred her to the kidney specialist. No further information provided regarding stomach issues. The event kidney tumor did not require emergency room visit. The patient visited physician office (stomach doctor) for issues with her stomach and he sent her for the CT scan and referred her to the kidney specialist. Furthermore, patient added she heard to wait a couple of weeks before or after the vaccine to get a mammogram and she thought she would ask about the CT and if anyone else had reported what she had with her kidney. The patient underwent lab test and procedure which includes CT scan on 03Apr2021 which showed kidney tumor. The patient had not yet recovered from kidney tumor while outcome of the other events was unknown.  Follow-up attempts are needed. Further information is expected.
Shot given Monday afternoon OK thru Wed nite, Thurs AM noticed lips swollen upon awakening, did not feel real well rest of Thurs. On Fri AM Temp 99.1 up to 101.5 by nite w/ HA, weakness, could hardly walk. Took fluids and rested, called nurse Fri eve. Sat = feeling better but noticed fiery red blotch on right leg size of her hand (lower leg) no discomfort. Felt bad about a day and a half. Recovered by Saturday AM.
Patient states - she initially had headache, L arm swelling and pain and it went away by day 5.  Then the site swelled again and is now red, itching and has minor pain.
This spontaneous report was received from a registered nurse and refers to 2 unspecified patients of unknown age and gender. No information about the patients' pertinent medical history, concomitant medications, drug reactions or allergies was provided. On 05-MAY-2017, the patients were vaccinated with doses of improperly stored VARIVAX lot # M027344 with expiration date on 01-JUN-2018 (dose and route of administration were not reported). The vaccine underwent a temperature excursion of 13 degrees Fahrenheit for 9 hours. Digital data logger was used to record the excursion. The vaccine underwent previous temperature excursion of 7 degrees Fahrenheit for 17 hours and 30 minutes. No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.; Sender's Comments: US-009507513-1706USA007148: US-009507513-1706USA007149: US-009507513-1706USA007150: US-009507513-1706USA007151: US-009507513-1706USA007152: US-009507513-1706USA007153: US-009507513-1706USA007154:
Per mother child received vaccines 6/22/11 at 2:30pm and about 2:00 am 6/23/11 developed fever 104.5 and was crying inconsolably. Parents took child to hospital, on admission to ED fever 104. No rash at that time. Rash developed 6/24/11 early AM.
Initial information received on 18 August 2009 from health care professional. A 17 to 18 years old female patient received MENACTRA (lot number unknown) subcutaneously on 14 August 2009. That evening, the patient was involved as a passenger in a car accident. The following day, the patient complained of a headache, achy eyes, back pain, a fever of 99 degrees, and a red, fine diffuse rash. On 18 August 2009 the patient was seen in the doctor's office. The patient was treated with Ibuprofen. At the time of the report, the patient had not recovered. List of Documents held by Sender: none.
Patient developed fever the first day after getting SHINGRIX and PNEUMOVAX immunizations. His arm got swollen and remained swollen till today (7/6/2018). Patient took BENADRYL and Ibuprofen and continued to ice the injection site but that did not relieve the symptoms. I advised the patient to go to the nearest emergency room.
Information has been received from a registered nurse and a medical assistant concerning a 27 year old female with seasonal allergies, a possible penicillin allergy and had a history of an abnormal Papanicolaou smear and loop electrosurgical excision procedure. On 8/2/06, the pt was vaccinated IM in the arm with the first 0.5ml pre filled syringe dose of HPV Vaccine (lot 653650/0640F). Concomitant therapy included unspecified hormonal contraceptive (reported as birth control pills). Following the first vaccination, the pt did not experience any adverse reactions. On 10/2/06, the pt was vaccinated with the second dose of HPV vaccine. On 10/2/06, 12 hours after the vaccination, the pt woke up in the middle of the night with right red, itchy hands and feet (also reported as soaked them in ice). It was reported that the symptoms were better the afternoon of the vaccination. On 10/3/06, the pt took Benadryl. The pt sought unspecified medical attention. On 10/4/06, the registered nurse spoke with the pt in the afternoon and all symptoms had resolved. The medical assistant note that the pt had no immediate severe symptoms. The medical assistant reported that there was no mention of seriousness of events in the pts chart and reported that the events did not look like they were serious. The registered nurse further reported that she would not classify the events as serious. Additional information has been requested.
bell's palsy twice in one side; This is a spontaneous report from a Pfizer-sponsored program, received from a contactable consumer (patient). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as unknown, single for COVID-19 immunization. Medical history included shingles went to eye two years ago. The patient's concomitant medications were not reported. The patient experienced bell's palsy twice in one side on an unspecified date with outcome of unknown.
dizzy spells/lightheaded; headaches; arm hurt a little; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizzy spells/lightheaded), HEADACHE (headaches) and VACCINATION SITE PAIN (arm hurt a little) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high and High cholesterol. Concomitant products included LOSARTAN, ATORVASTATIN, VENLAFAXINE and MULTIVITAMINS [VITAMINS NOS] for an unknown indication.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Jan-2021, the patient experienced DIZZINESS (dizzy spells/lightheaded), HEADACHE (headaches) and VACCINATION SITE PAIN (arm hurt a little). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, DIZZINESS (dizzy spells/lightheaded), HEADACHE (headaches) and VACCINATION SITE PAIN (arm hurt a little) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Patient was given the vaccine on 2/27/2023 .The first day after patient was administered the shot, the area grew hardened and swollen. The lump remained along with it being sore to touch on the  second day and third day.  On Friday 3/3/2023 around 2pm she complained that she had itchy bumps on her chest. I checked and she had raised, reddish skin all around her chest,  her waist and her eyes appeared swollen. I gave her a generic benadryl pill, she bathed and I applied calamine cream to her skin. On  Saturday morning,  the hives appeared less inflamed but around 5pm, they appeared raised again. The hives started to spread from  her chest,  and stomach to her back and inner thighs.  I gave her another generic benadryl pill and more cream.
Woke up having seizure, lasted at least one minute. Temp was 103 and was afebrile before bed and had a dose of Tylenol at about 9 pm before bed. Went to ER for evaluation.
This spontaneous report as received from a physician via company representative, and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not reported. On 03-APR-2014, the patient was vaccinated with a dose of improperly stored PNEUMOVAX 23 and lot number J009689 with expiration date of 29-JAN-2015 (route of administration was unknown), which was stored at 34 Fahrenheit (F) Degrees (1.111111111 Celsius) for a total of 144 hours. The vaccine status was reported as "in excursion". The vaccine storage criteria and the vaccine excursion were reported as "Refrigerator(R)". No adverse effect were reported nor product quality complaint was involved. This is one of several cases received from the same reporter. Additional information has been requested.
6 AM - 10 AM Golfed on 6/9/12 then around 10:15 A Pt. started feeling ill which lasted approx. 30 seconds. One hour later the pt. experienced the same feeling. At 1 PM pt. went to bed shivering w/ headache. Used heating pad and covers for relief. Pt. slept from 1 PM to 1 AM. Woke up wet w/ sweat. On 6-10-12 pt. woke up at 8 AM and felt like was recovering from flu all day. Muscle aches, joint aches, dull headache. On 6-11-12, 6 AM diarrhea, feverish and achy. Btn 10A - 11A had complete recovery.
first dose in 2018  and had not yet received the second dose; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 69-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received in 2018).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. At the moment of the call the health care professional was not in the work facility were they could find further information on the dose that was administrated. No further events were reported. Health care professional agreed to be contacted through email or phone number to be able to inform exact date of the first dose, expiration date and lot number of the vaccine. The reporter consented to follow up.
Within 15 minutes of injection, a metallic taste was in my month.; This is a spontaneous report from a contactable consumer, the patient. A female patient of unknown age received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 09Apr2021 at 13:00 as a single dose for COVID-19 immunisation. Medical history included allergy to tree nuts and chocolate. The patient received other medicines (unspecified) within two weeks prior to the COVID-19 vaccine. The patient previously received bacatracin (MANUFACTURER UNKNOWN) for unknown indication on an unknown date and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 13:15, within 15 minutes of injection, the patient experienced metallic taste in mouth. It was less the next day, but was still present. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event metallic taste in mouth was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Went into  Afib with RVR. Required treatment at emergency room. Heart rate converted. Only 7/5/21 again had episode of Afib, required treatment at hospital and admisson to hospital. Discharged requiring 3 medications. Now in controlled heart rate with  periods of normal sinus rhythm that goes into Afib and returns to normal rhtthm
CDC reports: 1 yo child developed fever 103, pain & swelling @ inject site, & rash following immunization.
Physician Discharge Summary     Patient ID:    Name:   Age: 79 y.o.  Birthday:  10/16/1942  Admit Date: 8/16/2022  9:00 PM  Discharge Date:  8/19/2022    Admitting Physician:   Discharge Physician.     Discharge Diagnosis:  Principal Problem:    Acute respiratory failure with hypoxemia  Active Problems:    Acute on chronic diastolic (congestive) heart failure    Gastroesophageal reflux disease with esophagitis without hemorrhage    Stage 3b chronic kidney disease    Hyperlipidemia    Essential hypertension    Atrial fibrillation           HPI: "Patient is a 79 y.o. female with a history below admitted for Acute respiratory failure with hypoxemia. Pt came in with complaints of worsening sob, malaise, occurring over several days, associated chills / fevers / nausea / body aches, but also leg swelling. Sob worse with exertion. No cp. Discussed with ER physician and will admit".     Hospital Course:  The patient was admitted to the hospital and was evaluated and treated per below.         * Acute respiratory failure with hypoxemia  Description of the Problem/Progression: New. O2 of 50. Clinically signs of chf. Covid +. cxr with bilateral infiltrates. Will treat both   Acute on chronic diastolic hf  Covid-19  Plan:   ?Pneumonia due to Covid 19 virus with acute respiratory failure with hypoxia. Improving on current treatment. Completed Remdesivir D5/5 and continued IV Decadron. Nebs and inhalers as ordered. Continue to follow up daily inflammatory markers and d-dimer. Patient continues with hypoxia resolved and was weaned off oxygen to RA. Continue nebs and inhalers. Encourage incentive spirometry use and pronating. Continue supportive/symptomatic treatment and supplements as ordered per COVID protocol. Follow up outpatient.    ?Acute on chronic diastolic heart failure. Improved with IV diuresis. Continue the same and monitor I and O's and daily weights.   ?Stage IIIB chronic kidney disease. Remains at baseline. Monitor closely with daily lab.   ?Paroxysmal atrial fibrillation. Controlled. Continue home medications and monitor on telemetry. Continue oral anticoagulation. Coumadin per pharmacy dosing.   ?Hypertension. Controlled. Continue same treatment. Follow up daily labs.    ?Hyperlipidemia. Continue statin therapy.             Physical Exam on the Date of Discharge:  Stable and improved.         Consults:    IP CONSULT TO HEART FAILURE NURSE  IP CONSULT TO DIETARY  IP CONSULT TO CARDIAC REHAB  IP CONSULT TO SOCIAL WORK  IP CONSULT TO WOUND CARE     Significant Diagnostic Studies:     labs, radiology, and cardiac graphics: per chart.        Disposition:  home     Discharge Condition:  good
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. On 25-MAR-2014 the patient was vaccinated with M-M-R II (lot # 0412AE; expiration date 27-FEB-2014). On 25-MAR-2014 the patient was administered a dose of expired M-M-R II. No adverse effect reported. Additional information has been requested.